APA (7th ed.) Citation

Kayser, S., Benner, A., Müller-Tidow, C., Ho, A. D., Schlenk, R. F., & Krämer, A. (2017). Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients. European journal of haematology, 99(6), . https://doi.org/10.1111/ejh.12972

Chicago Style (17th ed.) Citation

Kayser, Sabine, Axel Benner, Carsten Müller-Tidow, Anthony Dick Ho, Richard Friedrich Schlenk, and Alwin Krämer. "Clinical Impact of KMT2C and SPRY4 Expression Levels in Intensively Treated Younger Adult Acute Myeloid Leukemia Patients." European Journal of Haematology 99, no. 6 (2017). https://doi.org/10.1111/ejh.12972.

MLA (9th ed.) Citation

Kayser, Sabine, et al. "Clinical Impact of KMT2C and SPRY4 Expression Levels in Intensively Treated Younger Adult Acute Myeloid Leukemia Patients." European Journal of Haematology, vol. 99, no. 6, 2017, https://doi.org/10.1111/ejh.12972.